24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Intec Pharma
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
09:17
The man who sold Mellanox to Nvidia now fears Israel is losing its edge
08:53
Full list of Israeli high-tech funding rounds in 2025
08:51
Brandlight raises $5.75M to help brands win the AI search arms race
20:51
Deel CEO Alex Bouaziz surfaces in Dubai as Rippling struggles to serve lawsuit
More stories
Buzz
Most popular
Daily
Weekly
1
Intel’s breakup begins with sale of $8.75B-valued Altera to private equity giant Silver Lake
2
Deel CEO Alex Bouaziz surfaces in Dubai as Rippling struggles to serve lawsuit
3
Fintech Tapcheck raises $225M—$25M Series A extension and $200M facility—to expand real-time pay
4
Armis president sets bold goal: $1B in sales in three years, IPO in two
5
Deel CEO not served in Rippling lawsuit as whistleblower placed under 24/7 guard
More news
Intec Pharma
1 stories about Intec Pharma
Intec Pharma Announces Public Offering of Ordinary Shares on Nasdaq
11.04.18
|
Dror Reich
The pharmaceutical company is currently listed on Nasdaq and the Tel Aviv Stock Exchange. Investment firm Oppenheimer & Co.will serve as the sole book-running manager
